| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |